
1. j clin gastroenterol. 2015 nov-dec;49(10):873-7. doi:
10.1097/mcg.0000000000000325.

renal function chronic hepatitis b patients treated tenofovir disoproxil 
fumarate entecavir monotherapy: matched case-cohort study.

ha nb(1), ku k, ha nb, chaung kt, trinh hn, nguyen mh.

author information: 
(1)*school pharmacy, university california, san francisco, san francisco
†pacific health foundation ∥san jose gastroenterology, san jose ‡department of
medicine, santa clara valley medical center, santa clara §school medicine,
university california, davis, sacramento ¶division gastroenterology and
hepatology, stanford university medical center, palo alto, ca.

background aims: tenofovir (tdf)-associated renal dysfunction been
described various studies human immunodeficiency virus-infected patients.
our goal examine incidence magnitude decrease renal function 
in chronic hepatitis b patients treated tdf.
methods: performed case-cohort study 103 patients tdf 300 mg 103
patients unexposed tdf (entecavir) 4 centers, matched age±10
years, sex, baseline estimated glomerular filtration rate (egfr) group.
calculation evaluation egfr performed cockcroft-gault
formula modification diet renal disease formula.
results: exposed unexposed populations well matched similar
mean age (44±10 y), proportion male patients (63.1%), baseline egfr groups
(86.4% unimpaired). significant difference proportion of
patients reclassified severe renal classification (rmsrc) the
proportion patients decrease egfr ≥20% exposed tdf
versus control. incidence density rmsrc 7.4 cases per 100
patient-years exposed group compared 11.5 cases per 100 patient-years
in unexposed group (95% ci, 0.31-1.34). relative risk exposed to
unexposed 0.64 (95% ci, 0.31-1.34). cox proportional hazard analysis
following adjustment sex, age, baseline diagnosis hypertension, diabetes,
impaired baseline renal function, cirrhosis, tdf predictor for
rmsrc decrease egfr≥20%.
conclusions: tdf treatment independent predictor significant
deterioration renal function. renal function chronic hepatitis b patients
on antiviral therapy monitored, especially older
and/or mildly impaired renal function.

doi: 10.1097/mcg.0000000000000325 
pmid: 25856383  [indexed medline]

